FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,909,234 | -44.3% | 734,321 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $3,429,279 | +23.9% | 734,321 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,768,390 | +19.7% | 734,321 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,313,111 | +4.7% | 734,321 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,210,000 | +20.9% | 734,321 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $1,828,000 | -67.5% | 734,321 | 0.0% | 0.00% | -62.5% |
| Q1 2022 | $5,627,000 | +66.4% | 734,321 | 0.0% | 0.01% | +33.3% |
| Q4 2021 | $3,381,000 | -42.1% | 734,321 | 0.0% | 0.01% | -45.5% |
| Q3 2021 | $5,843,000 | -1.5% | 734,321 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $5,933,000 | -24.4% | 734,321 | 0.0% | 0.01% | -35.3% |
| Q1 2021 | $7,850,000 | – | 734,321 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,543,342 | 3.52% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,664,303 | 2.68% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $4,058,553 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,354,258 | $3,521,071 | 0.64% |
| Avidity Partners Management LP | 5,781,850 | $15,032,810 | 0.60% |
| Eagle Health Investments LP | 579,769 | $1,507,399 | 0.33% |
| Perceptive Advisors | 2,751,395 | $7,153,627 | 0.24% |
| Ghost Tree Capital, LLC | 243,287 | $632,546 | 0.21% |
| Sio Capital Management, LLC | 246,036 | $639,694 | 0.20% |
| Artal Group S.A. | 1,725,000 | $4,485 | 0.19% |